Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 24Lymphoma 13Leukemia 13Lymphoma, Follicular 12Rectal Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Congenital Abnormalities 7Ovarian Neoplasms 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Acute 6Kidney Neoplasms 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Neuroblastoma 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Central Nervous System Neoplasms 5Adenocarcinoma of Lung 5

Interventions

Filgrastim 20Etoposide 20Ifosfamide 19Cyclophosphamide 18Vincristine 13Radiotherapy 13Doxorubicin 13Peripheral Blood Stem Cell Transplantation 12Melphalan 12Carboplatin 10Busulfan 9Topotecan 8Temozolomide 8Magnetic Resonance Spectroscopy 8X-Rays 6Thiotepa 6Phantoms, Imaging 6Irinotecan 6Granulocyte Colony-Stimulating Factor 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Biopsy 5trioctyl phosphine oxide 4Mesna 4Docetaxel 4Dactinomycin 4temsirolimus 3etoposide phosphate 3cixutumumab 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors, Primitive, Peripheral × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00514345 2013-08-12

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

National Cancer Institute (NCI)

Unknown
300 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡